These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28491049)

  • 1. Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice.
    Bruinenberg VM; Gordijn MCM; MacDonald A; van Spronsen FJ; Van der Zee EA
    Front Neurol; 2017; 8():167. PubMed ID: 28491049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal microglia modifications in C57Bl/6 Pah
    van der Goot E; Bruinenberg VM; Hormann FM; Eisel ULM; van Spronsen FJ; Van der Zee EA
    Neurobiol Learn Mem; 2019 Apr; 160():139-143. PubMed ID: 29772389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
    PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of brain dysfunction in phenylketonuria.
    Martynyuk AE; van Spronsen FJ; Van der Zee EA
    Mol Genet Metab; 2010; 99 Suppl 1():S100-5. PubMed ID: 20123463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of sleep disorders in early-treated phenylketonuric children and adolescents. Correlation with dopamine and serotonin status.
    Gassió R; González MJ; Sans O; Artuch R; Sierra C; Ormazabal A; Cuadras D; Campistol J
    Eur J Paediatr Neurol; 2019 Sep; 23(5):685-691. PubMed ID: 31522993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?
    Stevenson M; McNaughton N
    Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.
    Schuck PF; Malgarin F; Cararo JH; Cardoso F; Streck EL; Ferreira GC
    Aging Dis; 2015 Sep; 6(5):390-9. PubMed ID: 26425393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    Bernsmeier C; Weisskopf DM; Pflueger MO; Mosimann J; Campana B; Terracciano L; Beglinger C; Heim MH; Cajochen C
    PLoS One; 2015; 10(11):e0143293. PubMed ID: 26576055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background.
    Bruinenberg VM; van der Goot E; van Vliet D; de Groot MJ; Mazzola PN; Heiner-Fokkema MR; van Faassen M; van Spronsen FJ; van der Zee EA
    Front Behav Neurosci; 2016; 10():233. PubMed ID: 28066199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire.
    Barta AG; Sumánszki C; Turgonyi Z; Kiss E; Simon E; Serfőző C; Reismann P
    Mol Genet Metab Rep; 2020 Jun; 23():100589. PubMed ID: 32346514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire.
    Jurecki E; Cunningham A; Birardi V; Gagol G; Acquadro C
    Health Qual Life Outcomes; 2017 Mar; 15(1):46. PubMed ID: 28274259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
    Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
    Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.
    Yıldız Y; Sivri HS
    Eur J Pediatr; 2019 Jul; 178(7):1005-1011. PubMed ID: 31053953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.